// App-Quantinova.ai

3597 : RPS3 regulates melanoma growth and sensitivity to DNA damage and predicts a poor prognosis by targeting ADT3

Researchers

Presenter

  • Yun Tian

Principal Investigators

  • Lijun Qin

  • Wei Guo

  • Changlin Zhang

  • Dingbo Shi

  • Tianze Liu

  • Wenbing Li

  • Jingshu Wang

  • Yixin Li

  • Ge Qin

  • Wendan Yu

  • Xiangsheng Xiao

  • Tiebang Kang

  • Wenlin Huang

  • Wuguo Deng

Medical Centers

  • Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc, Guagzhou, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

  • Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Skin carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved